Logo image of CMT

CORE MOLDING TECHNOLOGIES IN (CMT) Stock Fundamental Analysis

NYSEARCA:CMT - US2186831002 - Common Stock

19.79 USD
+0.34 (+1.75%)
Last: 9/5/2025, 8:05:28 PM
Fundamental Rating

6

Overall CMT gets a fundamental rating of 6 out of 10. We evaluated CMT against 83 industry peers in the Chemicals industry. While CMT has a great health rating, its profitability is only average at the moment. CMT has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CMT was profitable.
CMT had a positive operating cash flow in the past year.
Each year in the past 5 years CMT has been profitable.
Each year in the past 5 years CMT had a positive operating cash flow.
CMT Yearly Net Income VS EBIT VS OCF VS FCFCMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

The Return On Assets of CMT (4.25%) is better than 77.11% of its industry peers.
CMT has a Return On Equity of 6.10%. This is in the better half of the industry: CMT outperforms 67.47% of its industry peers.
The Return On Invested Capital of CMT (5.81%) is better than 66.27% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CMT is above the industry average of 6.34%.
Industry RankSector Rank
ROA 4.25%
ROE 6.1%
ROIC 5.81%
ROA(3y)7.3%
ROA(5y)5.79%
ROE(3y)11.32%
ROE(5y)9.32%
ROIC(3y)9.78%
ROIC(5y)8.36%
CMT Yearly ROA, ROE, ROICCMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 3.39%, CMT is in the better half of the industry, outperforming 61.45% of the companies in the same industry.
CMT's Profit Margin has improved in the last couple of years.
CMT's Operating Margin of 4.89% is on the low side compared to the rest of the industry. CMT is outperformed by 63.86% of its industry peers.
In the last couple of years the Operating Margin of CMT has grown nicely.
With a Gross Margin value of 17.50%, CMT is not doing good in the industry: 71.08% of the companies in the same industry are doing better.
CMT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.89%
PM (TTM) 3.39%
GM 17.5%
OM growth 3Y18.22%
OM growth 5YN/A
PM growth 3Y44.97%
PM growth 5YN/A
GM growth 3Y9.42%
GM growth 5Y18.42%
CMT Yearly Profit, Operating, Gross MarginsCMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CMT is still creating some value.
The number of shares outstanding for CMT has been reduced compared to 1 year ago.
Compared to 5 years ago, CMT has more shares outstanding
Compared to 1 year ago, CMT has an improved debt to assets ratio.
CMT Yearly Shares OutstandingCMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CMT Yearly Total Debt VS Total AssetsCMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

CMT has an Altman-Z score of 4.29. This indicates that CMT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CMT (4.29) is better than 89.16% of its industry peers.
The Debt to FCF ratio of CMT is 1.62, which is an excellent value as it means it would take CMT, only 1.62 years of fcf income to pay off all of its debts.
CMT's Debt to FCF ratio of 1.62 is amongst the best of the industry. CMT outperforms 92.77% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that CMT is not too dependend on debt financing.
The Debt to Equity ratio of CMT (0.12) is better than 89.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.62
Altman-Z 4.29
ROIC/WACC0.67
WACC8.66%
CMT Yearly LT Debt VS Equity VS FCFCMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

CMT has a Current Ratio of 2.85. This indicates that CMT is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CMT (2.85) is better than 80.72% of its industry peers.
A Quick Ratio of 2.36 indicates that CMT has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.36, CMT belongs to the best of the industry, outperforming 84.34% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.85
Quick Ratio 2.36
CMT Yearly Current Assets VS Current LiabilitesCMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2

3. Growth

3.1 Past

The earnings per share for CMT have decreased strongly by -39.18% in the last year.
Measured over the past years, CMT shows a very strong growth in Earnings Per Share. The EPS has been growing by 40.08% on average per year.
CMT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.64%.
The Revenue has been growing slightly by 1.24% on average over the past years.
EPS 1Y (TTM)-39.18%
EPS 3Y40.08%
EPS 5YN/A
EPS Q2Q%-27.4%
Revenue 1Y (TTM)-15.64%
Revenue growth 3Y-0.56%
Revenue growth 5Y1.24%
Sales Q2Q%-10.71%

3.2 Future

Based on estimates for the next years, CMT will show a small growth in Earnings Per Share. The EPS will grow by 5.66% on average per year.
CMT is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.74% yearly.
EPS Next Y-8.97%
EPS Next 2Y5.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-9.27%
Revenue Next 2Y-1.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CMT Yearly Revenue VS EstimatesCMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
CMT Yearly EPS VS EstimatesCMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2022 2023 2024 2025 2026 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.77, CMT is valued correctly.
Based on the Price/Earnings ratio, CMT is valued a bit cheaper than the industry average as 62.65% of the companies are valued more expensively.
CMT is valuated rather cheaply when we compare the Price/Earnings ratio to 27.06, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 11.66, the valuation of CMT can be described as very reasonable.
Based on the Price/Forward Earnings ratio, CMT is valued a bit cheaper than the industry average as 78.31% of the companies are valued more expensively.
CMT is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.77
Fwd PE 11.66
CMT Price Earnings VS Forward Price EarningsCMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CMT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CMT is cheaper than 91.57% of the companies in the same industry.
CMT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CMT is cheaper than 85.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.34
EV/EBITDA 5.53
CMT Per share dataCMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

CMT has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.66%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CORE MOLDING TECHNOLOGIES IN

NYSEARCA:CMT (9/5/2025, 8:05:28 PM)

19.79

+0.34 (+1.75%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-03 2025-11-03
Inst Owners68.59%
Inst Owner Change4.31%
Ins Owners7.19%
Ins Owner Change3.15%
Market Cap169.40M
Analysts80
Price Target22.44 (13.39%)
Short Float %2.56%
Short Ratio6.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.54%
Min EPS beat(2)-12.99%
Max EPS beat(2)14.08%
EPS beat(4)2
Avg EPS beat(4)-10.99%
Min EPS beat(4)-100%
Max EPS beat(4)54.97%
EPS beat(8)5
Avg EPS beat(8)49.77%
EPS beat(12)8
Avg EPS beat(12)73.37%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.58%
Min Revenue beat(2)-11.13%
Max Revenue beat(2)3.97%
Revenue beat(4)3
Avg Revenue beat(4)-0.23%
Min Revenue beat(4)-11.13%
Max Revenue beat(4)5.25%
Revenue beat(8)5
Avg Revenue beat(8)0.53%
Revenue beat(12)8
Avg Revenue beat(12)3.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-14.89%
EPS NQ rev (3m)-11.11%
EPS NY rev (1m)-20.35%
EPS NY rev (3m)-20.35%
Revenue NQ rev (1m)-12.96%
Revenue NQ rev (3m)-2.83%
Revenue NY rev (1m)-6.97%
Revenue NY rev (3m)-10.44%
Valuation
Industry RankSector Rank
PE 16.77
Fwd PE 11.66
P/S 0.61
P/FCF 13.34
P/OCF 7.12
P/B 1.1
P/tB 1.28
EV/EBITDA 5.53
EPS(TTM)1.18
EY5.96%
EPS(NY)1.7
Fwd EY8.57%
FCF(TTM)1.48
FCFY7.49%
OCF(TTM)2.78
OCFY14.05%
SpS32.26
BVpS17.93
TBVpS15.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.25%
ROE 6.1%
ROCE 7.49%
ROIC 5.81%
ROICexc 7.64%
ROICexgc 9.05%
OM 4.89%
PM (TTM) 3.39%
GM 17.5%
FCFM 4.6%
ROA(3y)7.3%
ROA(5y)5.79%
ROE(3y)11.32%
ROE(5y)9.32%
ROIC(3y)9.78%
ROIC(5y)8.36%
ROICexc(3y)11.4%
ROICexc(5y)9.43%
ROICexgc(3y)13.69%
ROICexgc(5y)11.53%
ROCE(3y)12.62%
ROCE(5y)10.78%
ROICexcg growth 3Y14.36%
ROICexcg growth 5YN/A
ROICexc growth 3Y16.49%
ROICexc growth 5YN/A
OM growth 3Y18.22%
OM growth 5YN/A
PM growth 3Y44.97%
PM growth 5YN/A
GM growth 3Y9.42%
GM growth 5Y18.42%
F-Score7
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.62
Debt/EBITDA 0.71
Cap/Depr 85.03%
Cap/Sales 4.02%
Interest Coverage 12.8
Cash Conversion 89.59%
Profit Quality 135.69%
Current Ratio 2.85
Quick Ratio 2.36
Altman-Z 4.29
F-Score7
WACC8.66%
ROIC/WACC0.67
Cap/Depr(3y)98.69%
Cap/Depr(5y)85.45%
Cap/Sales(3y)3.58%
Cap/Sales(5y)3.23%
Profit Quality(3y)108.24%
Profit Quality(5y)132.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-39.18%
EPS 3Y40.08%
EPS 5YN/A
EPS Q2Q%-27.4%
EPS Next Y-8.97%
EPS Next 2Y5.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.64%
Revenue growth 3Y-0.56%
Revenue growth 5Y1.24%
Sales Q2Q%-10.71%
Revenue Next Year-9.27%
Revenue Next 2Y-1.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.48%
EBIT growth 3Y17.56%
EBIT growth 5YN/A
EBIT Next Year107.53%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.49%
FCF growth 3Y189.18%
FCF growth 5Y20.65%
OCF growth 1Y-31.88%
OCF growth 3Y40.98%
OCF growth 5Y16.05%